HyBryte

synthetic hypericin · Soligenix

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HyBryte, covering 2023-06-07 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL [Phase 3]